TransMedics Group (TMDX) PT Raised to $174 at Needham
Tweet Send to a Friend
Needham analyst Mike Matson raised the price target on TransMedics Group (NASDAQ: TMDX) to $174.00 (from $166.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
